These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 558962)

  • 1. Protective effect of vaccines on Mycoplasma pulmonis-induced respiratory disease of mice.
    Taylor G; Howard CJ; Gourlay RN
    Infect Immun; 1977 May; 16(2):422-31. PubMed ID: 558962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection of mice against Mycoplasma pulmonis infection using purified mouse immunoglobulins: comparison between protective effect and biological properties of immunoglobulin classes.
    Taylor G; Howard CJ
    Immunology; 1981 Jul; 43(3):519-25. PubMed ID: 7251063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of active and passive immunization on Mycoplasma pulmonis-induced pneumonia in mice.
    Taylor G; Taylor-Robinson D
    Immunology; 1976 May; 30(5):611-8. PubMed ID: 1278933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Class-specific antibody responses to Mycoplasma pulmonis in sera and lungs of infected and vaccinated mice.
    Taylor G; Howard CJ
    Infect Immun; 1980 Sep; 29(3):1160-8. PubMed ID: 7429631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of vaccination against Mycoplasma pulmonis respiratory disease in rats.
    Cassell GH; Davis JK
    Infect Immun; 1978 Jul; 21(1):69-75. PubMed ID: 711323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic effect of DNA immunization of genetically susceptible mice infected with virulent Mycoplasma pulmonis.
    Lai WC; Pakes SP; Ren K; Lu YS; Bennett M
    J Immunol; 1997 Mar; 158(6):2513-6. PubMed ID: 9058780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of upper and lower respiratory tract immunity in resistance to Mycoplasma respiratory disease.
    Hodge LM; Simecka JW
    J Infect Dis; 2002 Jul; 186(2):290-4. PubMed ID: 12134269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors in resistance to and recovery from M. pulmonis-induced arthritis in mice.
    Taylor G; Taylor-Robinson D
    Ann Rheum Dis; 1977 Jun; 36(3):232-8. PubMed ID: 879860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Respiratory disease in a colony of rats. II. Isolation of Mycoplasma pulmonis from the natural disease, and the experimental disease induced with a cloned culture of this organism.
    Whittlestone P; Lemcke RM; Olds RJ
    J Hyg (Lond); 1972 Sep; 70(3):387-407. PubMed ID: 4506989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary intratracheal infection of mice with Mycoplasma pulmonis generates IgG1 memory B cells.
    Rose FV; Cebra JJ
    Isr J Med Sci; 1987 May; 23(5):490-5. PubMed ID: 3499421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential susceptibility to Mycoplasma pulmonis intranasal infection in X-linked immunodeficient (xid), severe combined immunodeficient (scid), and immunocompetent mice.
    Sandstedt K; Berglöf A; Feinstein R; Bölske G; Evengård B; Smith CI
    Clin Exp Immunol; 1997 Jun; 108(3):490-6. PubMed ID: 9182897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection of mice against experimental murine mycoplasmosis by a Mycoplasma pulmonis immunogen in lysogenized Escherichia coli.
    Lai WC; Bennett M; Gordon BE; Pakes SP
    Vaccine; 1994 Mar; 12(4):291-8. PubMed ID: 8178549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Murine respiratory mycoplasmosis: a model to study effects of oxidants.
    Davis JK; Davidson M; Schoeb TR
    Res Rep Health Eff Inst; 1991 Dec; (47):1-29; discussion 31-43. PubMed ID: 1838926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of pneumonia induced in mice with Mycoplasma pulmonis on resistance to subsequent bacterial infection and the effect of a respiratory infection with Sendai virus on the resistance of mice to Mycoplasma pulmonis.
    Howard CJ; Stott EJ; Taylor G
    J Gen Microbiol; 1978 Nov; 109(1):79-87. PubMed ID: 215702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoprophylaxis of experimental Mycoplasma pneumoniae disease: effect of route of administration on the immunogenicity and protective effect of inactivated M. pneumoniae vaccine.
    Greenberg H; Helms CM; Grizzard MB; James WD; Horswood RL; Chanock RM
    Infect Immun; 1977 Apr; 16(1):88-92. PubMed ID: 873618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of Mycoplasma pulmonis in cilia-associated respiratory bacillus isolates and in respiratory tracts of rats by nested PCR.
    Schoeb TR; Dybvig K; Keisling KF; Davidson MK; Davis JK
    J Clin Microbiol; 1997 Jul; 35(7):1667-70. PubMed ID: 9196170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycoplasmal adherence with particular reference to the pathogenicity of Mycoplasma pulmonis.
    Taylor-Robinson D; Furr PM; Davies HA; Manchee RJ; Mouches C; Bove JM
    Isr J Med Sci; 1981 Jul; 17(7):599-603. PubMed ID: 7026496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-17A Exacerbates Disease Severity in BALB/c Mice Susceptible to Lung Infection with Mycoplasma pulmonis.
    Mize MT; Sun XL; Simecka JW
    Infect Immun; 2018 Sep; 86(9):. PubMed ID: 29986888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycoplasma pulmonis infection of the murine oropharynx protects against subsequent vaginal colonization.
    Furr PM; Taylor-Robinson D
    Epidemiol Infect; 1993 Oct; 111(2):307-13. PubMed ID: 8405157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A modified live Mycoplasma gallisepticum vaccine to protect chickens from respiratory disease.
    Papazisi L; Silbart LK; Frasca S; Rood D; Liao X; Gladd M; Javed MA; Geary SJ
    Vaccine; 2002 Nov; 20(31-32):3709-19. PubMed ID: 12399199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.